Overview
Our commitment to cancer research has resulted in the launch of Liverpool Cancer Research UK Centre – an organisation that brings together scientists, clinicians and local stakeholders to lead and deliver cancer research of the highest quality and importance.
Haemato-oncology is one of Liverpool’s recognised strengths with scientific expertise in Chronic Myeloid Leukemia (CML) and lymphoproliferative disorders and strong clinical leadership that includes chairmanship of the National Cancer Research Institute (NCRI) Haematological Oncology CSG and CML Subgroup and membership of the Lymphoma CSG and Subgroups for Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML), High Grade Non-Hodgkin's Lymphomas (HG-NHL) and Low Grade Non-Hodgkin's Lymphomas (LG-NHL).
Professor Andrew Pettitt leads a large programme of clinical and translational research focussed on lymphoid malignancy with strong links with industry and national collaborative groups in lymphoma and haematological oncology.
* السعر الظاهر هو سعر توضيحي، يرجى تواصل مع الجامعة
فبراير 2025
University of Liverpool
The Foundation Building,
765 Brownlow Hill,
Liverpool,
L69 7ZX, NORTHERN ENGLAND, England
* السعر الظاهر هو سعر توضيحي، يرجى تواصل مع الجامعة
متوقع ديسمبر 2025
University of Liverpool
The Foundation Building,
765 Brownlow Hill,
Liverpool,
L69 7ZX, NORTHERN ENGLAND, England
قد يكون هناك متطلبات أيلتس مختلفة بناء على التخصص المحدد.
تعتبر جامعة ليفربول من الجامعات المشهورة التي تحمل عضوية مجموعة راسل، وهي جامعة عالمية رائدة تضم أكثر من 8 آلاف طالب دولي من أكثر من 130 دولة.